Literature Citations
1. Unveiling the Anti-tubercular Properties of Biscoumarins, through Biological Evaluation and Docking Studies. Acharya, P., M.M.V. Ramana, M. Upadhyay, and G. Pavale. Letters in Drug Design & Discovery, 2021. 18(1): p. 57-66. ISI[000631151000005].
[WOS]. TB_04_2021.
2. Discovery of Novel N(4)-Alkylcytidines as Promising Antimicrobial Agents. Alexandrova, L.A., M.V. Jasko, S.D. Negrya, P.N. Solyev, O.V. Shevchenko, A.P. Solodinin, D.P. Kolonitskaya, I.L. Karpenko, O.V. Efremenkova, A.A. Glukhova, Y.V. Boykova, T.A. Efimenko, N.V. Kost, D.A. Avdanina, G.K. Nuraeva, I.A. Volkov, S.N. Kochetkov, and A.A. Zhgun. European Journal of Medicinal Chemistry, 2021. 215: 113212. PMID[33582576].
[PubMed]. TB_04_2021.
3. New InhA Inhibitors Based on Expanded Triclosan and Di-triclosan Analogues to Develop a New Treatment for Tuberculosis. Chetty, S., T. Armstrong, S. Sharma Kharkwal, W.C. Drewe, C.I. De Matteis, D. Evangelopoulos, S. Bhakta, and N.R. Thomas. Pharmaceuticals, 2021. 14(4): 361. PMID[33919737]. PMCID[PMC8070701].
[PubMed]. TB_04_2021.
4. Osmium-arene Complexes with High Potency Towards Mycobacterium tuberculosis. Coverdale, J.P.C., C.S. Guy, H.E. Bridgewater, R.J. Needham, E. Fullam, and P.J. Sadler. Metallomics, 2021. 13(4): mfab007. PMID[33693931]. PMCID[PMC8026400].
[PubMed]. TB_04_2021.
5. Benzofuroxan Derivatives as Potent Agents against Multidrug-resistant Mycobacterium tuberculosis. Fernandes, G.F.S., D.L. Campos, I.C. Da Silva, J.L.B. Prates, A.R. Pavan, F.R. Pavan, and J.L. Dos Santos. ChemMedChem, 2021. 16(8): p. 1268-1282. PMID[33410233].
[PubMed]. TB_04_2021.
6. Discovery of Uncompetitive Inhibitors of SapM That Compromise Intracellular Survival of Mycobacterium tuberculosis. Fernández-Soto, P., J. Casulli, D. Solano-Castro, P. Rodríguez-Fernández, T.A. Jowitt, M.A. Travis, J.S. Cavet, and L. Tabernero. Scientific Reports, 2021. 11(1): 7667. PMID[33828158]. PMCID[PMC8027839].
[PubMed]. TB_04_2021.
7. Monocarbonyl curcuminoids as Antituberculosis Agents with Their Moderate in-Vitro Metabolic Stability on Human Liver Microsomes. Gagandeep, M. Singh, S. Kidawi, U.S. Das, T. Velpandian, R. Singh, and D.S. Rawat. Journal of Biochemical and Molecular Toxicology, 2021: e22754. PMID[33751730].
[PubMed]. TB_04_2021.
8. Discovery, Synthesis, and Optimization of Peptide-based Antibiotics. Hanna, C.C., Y.O. Hermant, P.W.R. Harris, and M.A. Brimble. Accounts of Chemical Research, 2021. 54(8): p. 1878-1890. PMID[33750106].
[PubMed]. TB_04_2021.
9. Blutaparon Portulacoides Ethanolic Extract Reduced Il-1β and Inflammatory Parameters Induced by the Mycobacterium Complex and Carrageenan in Mice. Kassuya, R.M., J.A.S. Radai, L.F.B. Macorini, V.K. Nunes, M.J. Salvador, P.R.T. Leite, R.J. Oliveira, J. Croda, A.C. Arena, and C.A.L. Kassuya. Inflammopharmacology, 2021. 29(2): p. 439-450. PMID[32910315].
[PubMed]. TB_04_2021.
10. Pt(IV)- or Mo(VI)-substituted Decavanadates Inhibit the Growth of Mycobacterium smegmatis. Kostenkova, K., Z. Arhouma, K. Postal, A. Rajan, U. Kortz, G.G. Nunes, D.C. Crick, and D.C. Crans. Journal of Inorganic Biochemistry, 2021. 217: 111356. PMID[33582396].
[PubMed]. TB_04_2021.
11. Thiosemicarbazide Derivatives Decrease the ATPase Activity of Staphylococcus aureus Topoisomerase IV, Inhibit Mycobacterial Growth, and Affect Replication in Mycobacterium smegmatis. Kowalczyk, A., A. Paneth, D. Trojanowski, P. Paneth, J. Zakrzewska-Czerwińska, and P. Stączek. International Journal of Molecular Sciences, 2021. 22(8): 3881. PMID[33918623]. PMCID[PMC8069432].
[PubMed]. TB_04_2021.
12. Biosynthetic Interrogation of Soil Metagenomes Reveals Metamarin, an Uncommon Cyclomarin Congener with Activity against Mycobacterium tuberculosis. Li, L., L.W. MacIntyre, T. Ali, R. Russo, B. Koirala, Y. Hernandez, and S.F. Brady. Journal of Natural Products, 2021. 84(4): p. 1056-1066. PMID[33621083]. PMCID[PMC8068612].
[PubMed]. TB_04_2021.
13. Novel Aminopyrazole Tagged Hydrazones as Anti-tubercular Agents: Synthesis and Molecular Docking Studies. Padmini, T., D. Bhikshapathi, K. Suresh, R. Kulkarni, and B.R. Kamal. Medicinal Chemistry, 2021. 17(4): p. 344-351. PMID[32407282].
[PubMed]. TB_04_2021.
14. Antibacterial Activity of a New Monocarbonyl Analog of Curcumin Mac 4 Is Associated with Divisome Disruption. Polaquini, C.R., B.C. Marques, G.M. Ayusso, L.G. Morão, J.C.O. Sardi, D.L. Campos, I.C. Silva, L.B. Cavalca, D.J. Scheffers, P.L. Rosalen, F.R. Pavan, H. Ferreira, and L.O. Regasini. Bioorganic Chemistry, 2021. 109: 104668. PMID[33601139].
[PubMed]. TB_04_2021.
15. Design, Synthesis, Pharmacological Evaluation, in Silico Modeling, Prediction of Toxicity and Metabolism Studies of Novel 1-(Substituted)-2-methyl-3-(4-oxo-2-phenylquinazolin-3(4H)-yl)isothioureas. Sulthana, M.T., V. Alagarsamy, and K. Chitra. Medicinal Chemistry, 2021. 17(4): p. 352-368. PMDI[32807063].
[PubMed]. TB_04_2021.
16. In Silico Guided Design of Non-covalent Inhibitors of DprE1: Synthesis and Biological Evaluation. Verma, H., S. Choudhary, M. Kumar, and O. Silakari. SAR and QSAR in Environmental Research, 2021. 32(4): p. 333-352. PMID[33784906].
[PubMed]. TB_04_2021.
17. Synthesis, Characterization and Biological Evaluation of New 3,5-disubstituted-pyrazoline Derivatives as Potential anti-Mycobacterium tuberculosis H37Ra Compounds. Wong, K.T., H. Osman, T. Parumasivam, U. Supratman, M.T. Che Omar, and M.N. Azmi. Molecules, 2021. 26(7): 2081. PMID[33916423]. PMCID[PMC8038544].
[PubMed]. TB_04_2021.
18. Synthesis and Antibacterial Activity of Polymer-antibiotic Conjugates Incorporated into a Resin-based Dental Adhesive. Zhang, Z., M.M. Jones, C. Sabatini, S.T. Vanyo, M. Yang, A. Kumar, Y. Jiang, M.T. Swihart, M.B. Visser, and C. Cheng. Biomaterials Science, 2021. 9(6): p. 2043-2052. PMID[33464241]. PMCID[PMC7990707].
[PubMed]. TB_04_2021.
Patent Citations
This month, no relevant Mycobacterium articles were identified.